Cargando…
Improvement of Arterial Wall Lesions in Parallel with Decrease of Plasma Pentraxin-3 Levels in a Patient with Refractory Takayasu Arteritis after Treatment with Tocilizumab
A 19-year-old Japanese woman with active Takayasu arteritis despite multiple conventional immunosuppressive therapies with glucocorticoids in combination with intravenous cyclophosphamide, azathioprine, or infliximab with methotrexate and tacrolimus was successfully treated by switching from inflixi...
Autores principales: | Iwagaitsu, Shiho, Naniwa, Taio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476896/ https://www.ncbi.nlm.nih.gov/pubmed/28676840 http://dx.doi.org/10.1155/2017/4580967 |
Ejemplares similares
-
Successful Use of Higher-Dose Etanercept for Multirefractory Systemic Flare of Adult-Onset Still's Disease with Liver Failure with No Response to Tocilizumab Therapy
por: Naniwa, Taio, et al.
Publicado: (2013) -
Effectiveness of Tocilizumab in juvenile patients with refractory Takayasu arteritis: Two case reports
por: Asano, Tomoyuki, et al.
Publicado: (2020) -
Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review
por: Li, Haiyan, et al.
Publicado: (2021) -
Tocilizumab for faster and safer remission of Takayasu’s arteritis
por: Liao, Hua, et al.
Publicado: (2022) -
Systematic review and meta-analysis of the current literature on tocilizumab in patients with refractory Takayasu arteritis
por: Kang, Limei, et al.
Publicado: (2023)